Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

Chapters:

0:00 Novel Cas enzymes help overcome CRISPR challenges

11:37 New pipeline of therapies will go after novel targets

14:52 How does the new platform open up possibilities for new diagnostics?

21:05 What risks do you think about?

26:47 What are the company’s two-year goals?

31:07 On the possibilities

CRISPR technology is enabling a new generation …